Raymond James & Associates Amedisys Inc Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 25, 2023	SELL	$73.99 - $92.6 $15,093 - $18,890	-204 Reduced 3.41%	5,780 $528,000
Q1 2023 Apr 14, 2023	SELL	$69.79 - $100.33 $28,055 - $40,332	-402 Reduced 6.3%	5,984 $440,000
Q4 2022 Feb 08, 2023	SELL	$80.12 - $105.34 $132,438 - $174,127	-1,653 Reduced 20.56%	6,386 $533,000
Q3 2022 Oct 25, 2022	SELL	$96.79 - $131.14 $135,118 - $183,071	-1,396 Reduced 14.8%	8,039 $778,000
Q2 2022 Aug 12, 2022	SELL	$105.12 - $173.85 $175,129 - $289,634	-1,666 Reduced 15.01%	9,435 $992,000
Q1 2022 May 11, 2022	BUY	$124.79 - $178.09 $84,857 - $121,101	680 Added 6.53%	11,101 $1.91 Million
Q4 2021 Feb 08, 2022	SELL	$136.32 - $184.41 $910,617 - $1.23 Million	-6,680 Reduced 39.06%	10,421 $1.69 Million
Q3 2021 Nov 02, 2021	BUY	$149.1 - $270.32 $965,124 - $1.75 Million	6,473 Added 60.91%	17,101 $2.55 Million
Q2 2021 Aug 11, 2021	BUY	$238.97 - $288.5 $40,385 - $48,756	169 Added 1.62%	10,628 $2.6 Million
Q1 2021 May 14, 2021	SELL	$236.62 - $314.16 $916,665 - $1.22 Million	-3,874 Reduced 27.03%	10,459 $2.77 Million
Q4 2020 Feb 12, 2021	BUY	$231.3 - $293.33 $35,157 - $44,586	152 Added 1.07%	14,333 $4.2 Million
Q3 2020 Nov 04, 2020	SELL	$199.22 - $248.1 $104,789 - $130,500	-526 Reduced 3.58%	14,181 $3.35 Million
Q2 2020 Jul 28, 2020	BUY	$169.77 - $213.81 $122,573 - $154,370	722 Added 5.16%	14,707 $2.92 Million
Q1 2020 Apr 21, 2020	BUY	$137.21 - $202.02 $955,530 - $1.41 Million	6,964 Added 99.19%	13,985 $2.57 Million
Q4 2019 Feb 12, 2020	BUY	$122.85 - $167.13 $124,938 - $169,971	1,017 Added 16.94%	7,021 $1.17 Million
Q3 2019 Nov 07, 2019	SELL	$117.97 - $137.89 $127,289 - $148,783	-1,079 Reduced 15.23%	6,004 $787,000
Q2 2019 Aug 06, 2019	SELL	$108.08 - $129.67 $75,115 - $90,120	-695 Reduced 8.94%	7,083 $860,000
Q1 2019 May 06, 2019	BUY	$110.76 - $138.73 $66,012 - $82,683	596 Added 8.3%	7,778 $959,000
Q4 2018 Feb 11, 2019	BUY	$98.2 - $140.23 $319,641 - $456,448	3,255 Added 82.89%	7,182 $841,000
Q3 2018 Nov 14, 2018	BUY	$87.74 - $125.01 $344,554 - $490,914	3,927 New	3,927 $491,000
Q3 2017 Nov 13, 2017	SELL	$47.05 - $55.96 $158,934 - $189,032	-3,378 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	3,378	3,378 $212,000

Others Institutions Holding AMED

# of Institutions

297

Shares Held

28.5M

Call Options Held

181K

Put Options Held

1.04M

Vanguard Group Inc Valley Forge, PA

3.21M
Shares

$291 Million
0.01% of portfolio
Black Rock Inc. New York, NY

3.1M
Shares

$282 Million
0.01% of portfolio
Fil LTD Hamilton, D0

1.31M
Shares

$119 Million
0.12% of portfolio
Westchester Capital Management, LLC Valhalla, NY

1.12M
Shares

$102 Million
5.22% of portfolio
Pentwater Capital Management LP Naples, FL

1.08M
Shares

$97.7 Million
1.08% of portfolio

View Full List

About AMEDISYS INC

Ticker AMED
Exchange NASDAQ
Sector Healthcare
Industry Medical Care Facilities
Shares Outstandng 32,492,000
Market Cap $2.95B
Description
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal...

More about AMED

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account